Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys

Dopaminergic medications ameliorate many of the motor impairments of Parkinson’s disease (PD). However, parkinsonism is often only partially reversed by these drugs, and they can have significant side effects. Therefore, a need remains for novel treatments of parkinsonism. Studies in rodents and pre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ACS Chem Neurosci
Egile Nagusiak: Galvan, Adriana, Devergnas, Annaelle, Pittard, Damien, Masilamoni, Gunasingh, Vuong, Jocelyn, Daniels, J. Scott, Lindsley, Craig W., Morrison, Ryan D., Wichmann, Thomas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510653/
https://ncbi.nlm.nih.gov/pubmed/27596273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00186
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak